The identification of disease-induced biomarkers in the urine of BSE infected cattle.
BACKGROUND
The bovine spongiform encephalopathy (BSE) epidemic and the emergence of a new human variant of Creutzfeldt-Jakob Disease (vCJD) have led to profound changes in the production and trade of agricultural goods. The rapid tests currently approved for BSE monitoring in slaughtered cattle are all based on the detection of the disease related isoform of the prion protein, PrPd, in brain tissue and consequently are only suitable for post-mortem diagnosis.


OBJECTIVE
In instances such as assessing the health of breeding stock for export purposes where post-mortem testing is not an option, there is a demand for an ante-mortem test based on a matrix or body fluid that would permit easy access and repeated sampling. Urine and urine based analyses would meet these requirements.


RESULTS
Two dimensional differential gel eletrophoresis (2D-DIGE) and mass spectrometry analyses were used to identify proteins exhibiting differential abundance in the urine of BSE infected cattle and age matched controls over the course of the disease. Multivariate analyses of protein expression data identified a single protein able to discriminate, with 100% accuracy, control from infected samples. In addition, a subset of proteins were able to predict with 85% +/- 13.2 accuracy the time post infection that the samples were collected.


CONCLUSIONS
These results suggest that in principle it is possible to identify biomarkers in urine useful in the diagnosis, prognosis and monitoring of disease progression of transmissible spongiform encephalopathy diseases (TSEs).
Simon
Sharon L R
SL
Public Health Agency of Canada, Winnipeg, Canada. sharon_simon@phac-aspc.gc.ca
Lamoureux
Lise
L
Plews
Margot
M
Stobart
Michael
M
LeMaistre
Jillian
J
Ziegler
Ute
U
Graham
Catherine
C
Czub
Stefanie
S
Groschup
Martin
M
Knox
J David
JD
Neurochem Res. 2008 Jul;33(7):1332-40
18288611
Kidney Int. 2002 Dec;62(6):2184-94
12427144
J Biol Chem. 2001 Aug 24;276(34):31479-82
11423531
Proteomics. 2007 Apr;7(8):1197-207
17366473
Crit Rev Clin Lab Sci. 2004;41(5-6):467-550
15603510
Mol Cell Proteomics. 2006 Oct;5(10):1760-71
16837576
Proteomics. 2005 Aug;5(12):3105-15
16035117
Toxicol Pathol. 2007 Apr;35(3):376-82
17455085
J Neuroimmunol. 2005 May;162(1-2):12-8
15833355
Expert Rev Mol Diagn. 2006 Jul;6(4):597-611
16824033
Methods Mol Biol. 2007;367:219-39
17185779
Int J Biochem Cell Biol. 2002 May;34(5):427-31
11906815
Folia Neuropathol. 2004;42 Suppl A:85-91
15449463
Cell Tissue Res. 2002 Dec;310(3):289-96
12457227
Clin Chim Acta. 2002 Sep;323(1-2):121-8
12135813
J Proteome Res. 2007 Nov;6(11):4189-99
17929958
Nat Med. 2006 Jun;12(6):636-41
16751768
Neuropathol Appl Neurobiol. 2007 Aug;33(4):373-94
17617870
Neurodegener Dis. 2006;3(3):123-8
16954698
Nature. 2001 Jun 14;411(6839):810-3
11459061
J Biol Chem. 2004 May 28;279(22):23661-7
15031285
Nat Methods. 2007 Aug;4(8):645-50
17643109
J Virol. 2004 Feb;78(4):2088-99
14747574
Br Med Bull. 2003;66:185-98
14522859
Nat Med. 2006 Jun;12(6):607-8
16760999
J Biol Chem. 2004 Nov 19;279(47):48817-20
15310752
Nat Methods. 2007 Aug;4(8):614-6
17664944
Proteomics. 2003 Jan;3(1):36-44
12548632
J Gen Virol. 2007 Mar;88(Pt 3):1048-1055
17325380
J Gen Virol. 2007 Oct;88(Pt 10):2890-2898
17872544
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20914-9
18096717
Cell. 1983 Nov;35(1):57-62
6414721
Acta Neuropathol. 2002 Mar;103(3):199-208
11907798
J Pediatr Gastroenterol Nutr. 2006 Jul;43 Suppl 1:S74-81
16819406